Comparison of serum IL-18 levels in tuberculosis with pneumonia, lung cancer and healthy controls Source: Eur Respir J 2003; 22: Suppl. 45, 340s Year: 2003
Clinical value of measurements of interleukin-2 soluble receptor in blood of lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002
Correlation of serum TNF-α, IL-4 and sIL-2R levels with radiologic and clinical manifestations in active pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 339s Year: 2003
Comparison of serum CA-125 levels in pulmonary tuberculosis, pleural tuberculosis and treated active pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 453s Year: 2005
High serum periostin levels and the association with pulmonary tuberculosis Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018
The relationship between serum soluble interleukin-2 receptor levels and disease severity in sarcoidosis Source: Eur Respir J 2006; 28: Suppl. 50, 355s Year: 2006
Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003
Levels of IL-1β and TNFα production in patients with lung tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 315s Year: 2002
Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis Source: Annual Congress 2011 - Novel strategies for the diagnosis of tuberculosis Year: 2011
The contribution of serum ferritin, iron, iron binding capacity and bronchoalveolar lavage ferritin levels in differential diagnosis of lung cancer from benign pulmonary diseases Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007
The importance of cortisol level in differential diagnostic between lung tuberculosis and sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
CEA levels in the serum and induced sputum of lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 324s Year: 2005
Serum and r32kd induced cytokine levels and expression in tuberculosis patients and contacts Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: diagnostic tools Year: 2012
Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Pleural and systemic cytokine expression profiles in patients with lung cancer Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018
Serum levels of vascular endothelial growth factor in the differential diagnosis of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002
Serum IFN-γ and TNF-α levels in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 456s Year: 2005
Neopterin levels differential diagnosis of active and inactive pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006
The clinical significance of serum interleukin 18 concentration in lung cancer Source: Eur Respir J 2003; 22: Suppl. 45, 394s Year: 2003
Clinical value of soluble interleukine-2 receptor (sIL-2R) serum level examination in the pulmonary sarcoidosis (PS) Source: Eur Respir J 2003; 22: Suppl. 45, 226s Year: 2003